EUVIMEDOtkrijte EUVIMED
CrossrefInformacijska kartica

Psychometric properties of the Turkish version of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory

DENİZ UĞUR CENGİZ, FEYZA İNCEOĞLU, ERCAN KARABABA, BÜLENT SATAR, HATİCE SEYRA ERBEK, TUBA BAYINDIR, BÜŞRA KURTCU, SANEM CAN ÇOLAK, MEHMET KADİR ERCAN, EMRE SÖYLEMEZ, METİN YÜKSEL AKYILDIZ, YÜCE İSLAMOĞLU, BENGİ ARSLAN, SÜMEYYE DEMİREL BİRİŞİK, EMRE AKGÜN ÖZDEMİR, İSMAİL DEMİR, AHMET ADIGÜZEL

Turkish Journal of Medical Sciences · 2024-10-18 · 54 (5) · 979-988

DOI: 10.55730/1300-0144.5876 ↗
SažetakBibliografski podaci

Sažetak

Background/aimThere are insufficient tools to assist in the diagnosis and treatment of vestibular migraine. The aim of the study to perform the Turkish adaptation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI).Materials and methodsAfter language and content validity was completed, a pilot study was conducted. Exploratory and confirmatory factor analyzes were conducted to test construct validity, and as a result of validity analyses, Cronbach α internal consistency coefficient and test-retest analyzes were conducted for reliability.ResultsIn the study in which 289 participants were evaluated, the Kaiser-Meyer-Olkin coefficient was calculated as 0.903. The percentage of variance explained by the explanatory factor analysis was 67.246% and the range of factor load change was 0.433-0.828. The scale structure was tested with confirmatory factor analysis and the model was confirmed with adequate goodness of fit index values. Cronbach's α internal consistency coefficient of the scale was 0.931.ConclusionThe VM-PATHI is a valid and reliable tool for the subjective evaluation of vestibular migraine in Türkiye.

Znanje koje odgovara vašem radu.

Od besplatnog početka i osobnog pretraživanja literature do potpunog paketa Research Suite.

Prikaži tarife →

Jesu li uključeni svi cjeloviti tekstovi izdavača?

Ne. Bibliografski zapisi, sažeci i cjeloviti tekstovi različiti su sadržaji. Hoće li cjeloviti tekst biti dostupan ovisi o izvoru, Open Accessu i vašim postojećim licencama. Tarifa EUVIMED ne zamjenjuje dodatna izdavačka prava.

Prikaži tarife →